Cite
MLA Citation
Derek Alderson et al.. “Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.” Lancet oncology, vol. 18, no. 9, n.d., pp. 1249–1260. http://access.bl.uk/ark:/81055/vdc_100049766196.0x000019